Bamlanivimab and etesevimab administered together neutralize the Delta variant, which is currently the cause of over 95 percent of new COVID-19 infections in the EU/EEA Participating EU/EEA countries can purchase… Read More
4IR Solutions Launches FactoryStack™ to Help Manufacturers Improve Operations with a curated Platform-as-a-Service (PaaS) BURLINGTON, ON — Grantek has named 4IR Solutions as a Strategic Partner focused on Cloud technologies…. Read More
Nasal decolonization is recommended by the WHO and CDC to reduce hospital acquired infections (HAIs), [1] which have been exacerbated by COVID. [2] HAIs in U.S. hospitals cause up to… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, will report financial results for the fiscal… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announces that Eric A. Adams, CEO… Read More
